Fosun Pharma Rumored to Offer $480 Million for Lumenis of Israel

Shanghai Fosun Pharma is rumored to be in talks to acquire Lumenis Ltd., an Israeli medical device company. Fosun is reportedly willing to pay $480 million for Lumenis, which makes laser, pulsed light and RF frequency devices for aesthetic uses as well as other minimally invasive procedures. In 2013, Fosun paid $240 million for another Israeli aesthetic device company, Alma Lasers. According to reports, Fosun plans to merge the companies into one. More details.... Stock Symbols: (SHA: 600196; HK: 02196) (NSDQ: LMNS) Share this with colleagues: // //